Welcome to the Investor Center
Imaginatik enjoyed a strong close to the first half year, growing turnover by 26% despite the backdrop of a challenging global economy. We secured several significant multi-year deals with organisations in insurance, manufacturing, financial services and healthcare.
Innovation is firmly back on the corporate agenda, as is the use of collaboration software to support innovation. As one of the pioneers in the space, we are delighted that industry analysts predict Idea Management to be on track to be a mainstream business application within the next two years, having successfully navigated the technology ‘chasm’. So far this year we have made significant investments in sales, marketing and in our core software platform, and we are confident that we will be able to take advantage of our current and future market opportunity as the market expands.
- Mark Turrell, CEO
Share Price Information
Imaginatik is listed on the London Stock Exchange Alternative Investment Market [ LSE: IMTK.L ] and there are no restrictions on the transfer of its AIM securities.
Click here to see Imaginatik's current share price, latest share trades, and statistics provided by the London Stock Exchange.
Additional trades take place on PLUS Markets. Click here for Plus Trading Data and the Plus Overview [ IMTK.GB ].
Imaginatik also has an Unsupported ADR provided by Deutsche Bank [ IMGKY ] and is quoted in the US [ OTC: IMGKF ].
Share Capital
| |
Number |
% |
| Number of AIM securities in issue |
159,223,876 |
100 |
| AIM securities not in public hands |
|
51.95 |
|
| Significant Shareholders (as of 4 December 2009) |
| Mark Turrell |
76,076,666 |
47.78 |
| Octopus Asset Management |
24,546,000 |
15.42 |
| Artemis Investment Management |
12,166,667 |
7.64 |
| Williams de Broe |
10,516,666 |
6.60 |
| Pfizer Inc. |
8,035,885 |
5.05 |
| Wills & Co. |
3,271,000 |
2.05 |
Financial Calendar & Investor Events
- Financial year end date: 31 March
- Preliminary results announcement date: June 2010
- AGM date: July 2010
- Interim results announcement date: November 2010
Further Investor Information
Click here for company directors and committees.
Click here for Imaginatik's RNS and RNS Reach announcements.
Click here for company information: advisors and company registration details.
Click here for Imaginatik's reports and accounts and its constitutional documents.
Click here for investor contacts.
The above information is disclosed in accordance with AIM rule 26 and was last updated on 22 December 2009.